ARS EU Spółka z Ograniczoną Odpowiedzialnością (KRS 0000996490, NIP 5130281460) is a Polish company, headquartered in Modlnica, Małopolskie voivodeship. ARS EU operates in: Non-specialised wholesale trade (PKD 46.90.Z). Industry: Wholesale trade. The company has been listed in the National Court Register since October 11, 2022. ARS EU's most recently reported net revenue was 5.0 M PLN for 2024.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - ARS EU
Identity
- Name
- ARS EU Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- October 11, 2022
- Registry status as of
- July 21, 2026
- Latest entry
- July 21, 2026
- Founding act
- 22.09.2022 R.
Articles of association history (1)
- September 22, 2022: 22.09.2022 R.
Activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. JURAJSKA, 2D, 32-085, MODLNICA, POLSKA
- Voivodeship
- MAŁOPOLSKIE
- District
- KRAKOWSKI
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - ARS EU
Credibility rating
44.1 / 100
Average credibility
Insolvency risk
Very low
Elevated threat
Closure risk
17
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/4 yrs
Board changes
0
0/4 yrs
PKD changes
0
0/4 yrs
Name changes
0
0/4 yrs
Data from 4 years of registry activity.
Credibility history
Payment reliability score from 2023–2024
Current: D (44/100)
Trend: deteriorating (-31.1 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Trade credit limit history
Standard limit from 2023–2024
Current: 165.2 K PLN
Safe: 49.6 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - ARS EU
Founded
October 11, 2022
3 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
MODLNICA
MAŁOPOLSKIE
Primary PKD
46.90.Z
Non-specialised wholesale trade
Share capital
5.0 K PLN
100 shares total
Shareholders
1
shareholder
Board
1 person
Proxies: 2
Filed years
2 years
2023–2024
Registry entries
13
latest: July 21, 2026
Revenue
5.0 M PLN
2024
Net profit
18.0 K PLN
2024
Assets
1.7 M PLN
2024
Equity
398.8 K PLN
2024
EBITDA
N/A
2024
no depreciation data
Valuation
261.6 K PLN
High confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - ARS EU.
No ratings
Related articles
Explainer
Eurocash in 2026: Poland's FMCG-wholesale leader and the Delikatesy Centrum network – an mWIG40 issuer near Poznań controlled by Luis Amaral
Eurocash S.A. (KRS 0000213765), headquartered at ul. Wiśniowa 11 in Komorniki near Poznań, is the leader of Poland's FMCG-wholesale distribution and the operator of the 1,500+ Delikatesy Centrum store network. Founded in 1995 by Portuguese entrepreneur Luis Amaral and listed on the WSE since 2005, the company is an mWIG40 constituent. Its 2025 financial statements show revenue of around PLN 30.0bn and a net loss of about PLN 336m. A six-member management board and a five-member supervisory board chaired by the founder.
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by a gradual normalisation. Listed on the WSE since 2013, with a three-member management board and a five-member supervisory board.
